[eLong Statement Regarding Dispute with Qunar BEIJING, October 16, 2013. – eLong, Inc. (NASDAQ: LONG), released the following statement regarding a legal dispute with Qunar: We recently have noticed a number of public statements regarding a contract dispute between eLong and Qunar. We would like to clarify some of the facts relating to this dispute, and set forth our position]
[eLong Statement Regarding Dispute with Qunar BEIJING, October 16, 2013. – eLong, Inc. (NASDAQ: LONG), released the following statement regarding a legal dispute with Qunar: We recently have noticed a number of public statements regarding a contract dispute between eLong and Qunar. We would like to clarify some of the facts relating to this dispute, and set forth our position]
[Schedule 14A x o Check the appropriate box: o o x o o Biostar Pharmaceuticals, Inc. _____________________________________ Payment of Filing Fee (Check the appropriate box): x o (1) Title of each class of securities to which transaction applies: _____________________________ (2) Aggregate number of securities to which transaction applies: ____________________________ (3) (4) Proposed maximum aggregate value of transaction: ______________________________________ (5)]
[eLong Statement Regarding Dispute with Qunar BEIJING, October 16, 2013. eLong, (NASDAQ: LONG), released the following statement regarding a legal dispute with Qunar: We recently have noticed a number of public statements regarding antract dispute between eLong and Qunar. We would like to clarify some of the facts relating to this dispute, and set forth]
[eLong Statement Regarding Dispute with Qunar BEIJING, October 16, 2013. eLong, (NASDAQ: LONG), released the following statement regarding a legal dispute with Qunar: We recently have noticed a number of public statements regarding antract dispute between eLong and Qunar. We would like to clarify some of the facts relating to this dispute, and set forth]
[SIMPSON THACHER & BARTLETT ICBC TOWER, 35TH FLOOR 3 GARDEN ROAD HONG KONG (852) 2514-7600 FACSIMILE (852) 2869-7694 DIRECT DIAL NUMBER (852) 2514-7630 EMAIL ADDRESS lchen@stblaw.com VIA EDGAR October 16, 2013 Amanda Ravitz Mary Beth Breslin Tim Buchmiller Division of Corporation Finance 100 F Street, N.E. Re: Yingli Green Energy Holding Company Limited Registration Statement on Form F-3 Filed September]
[SIMPSON THACHER & BARTLETT ICBC TOWER, 35TH FLOOR 3 GARDEN ROAD HONG KONG (852) 2514-7600 FACSIMILE (852) 2869-7694 DIRECT DIAL NUMBER (852) 2514-7630 EMAIL ADDRESS lchen@stblaw.com VIA EDGAR October 16, 2013 Amanda Ravitz Mary Beth Breslin Tim Buchmiller Division of Corporation Finance 100 F Street, N.E. Re: Yingli Green Energy Holding Company Limited Registration Statement on Form F-3 Filed September]
[] [16 October, 2013 Matter No.:M#878535 Doc Ref: DML/RW/4058640.1 Yingli Green Energy Holding Company Limited No. 3399 Chaoyang North Street Baoding 071051 Peoples Republic of China Dear Sirs, Yingli Green Energy Holding Company Limited (the Company) Commission Registration Statement Securities Act Ordinary Shares Rights Preferred Shares Equity Securities Debt Securities Securities For the purposes of giving this opinion, we have examined]
[] [16 October, 2013 Matter No.:M#878535 Doc Ref: DML/RW/4058640.1 Yingli Green Energy Holding Company Limited No. 3399 Chaoyang North Street Baoding 071051 Peoples Republic of China Dear Sirs, Yingli Green Energy Holding Company Limited (the Company) Commission Registration Statement Securities Act Ordinary Shares Rights Preferred Shares Equity Securities Debt Securities Securities For the purposes of giving this opinion, we have examined]
[Schedule 14A x o Check the appropriate box: o o x o o Biostar Pharmaceuticals, Inc. _____________________________________ Payment of Filing Fee (Check the appropriate box): x o (1) Title of each class of securities to which transaction applies: _____________________________ (2) Aggregate number of securities to which transaction applies: ____________________________ (3) (4) Proposed maximum aggregate value of transaction: ______________________________________ (5)]
